Abstract
The 5-HT7 receptor (5-HT7R), characterized in 1993, is the most recently described member of the serotonin family. Since its discovery, 5-HT7R has been the subject of extensive research due to its widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to illustrate the literature concerning developments of the last few years (2007-2010) towards the discovery of novel and selective 5-HT7R ligands, agonists, antagonist and inverse agonists.
Keywords: 5-HT7R, 5-HT7 ligands, agonists, antagonists, G protein-coupled receptors, serotonin, serotonin receptor subtypes, CNS, PNS, GPCRs
Mini-Reviews in Medicinal Chemistry
Title: Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands
Volume: 11 Issue: 13
Author(s): V. Pittala and D. Pittala
Affiliation:
- Dipartimento di Scienze del Farmaco, Facolta di Farmacia, Universita di Catania, Viale A. Doria 6, 95125 Catania, Italy.,Italy
Keywords: 5-HT7R, 5-HT7 ligands, agonists, antagonists, G protein-coupled receptors, serotonin, serotonin receptor subtypes, CNS, PNS, GPCRs
Abstract: The 5-HT7 receptor (5-HT7R), characterized in 1993, is the most recently described member of the serotonin family. Since its discovery, 5-HT7R has been the subject of extensive research due to its widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to illustrate the literature concerning developments of the last few years (2007-2010) towards the discovery of novel and selective 5-HT7R ligands, agonists, antagonist and inverse agonists.
Export Options
About this article
Cite this article as:
Pittala V. and Pittala D., Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands, Mini-Reviews in Medicinal Chemistry 2011; 11(13) . https://dx.doi.org/10.2174/138955711797655353
| DOI https://dx.doi.org/10.2174/138955711797655353 |
Print ISSN 1389-5575 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Allegations from Whistleblowers
- Publishing Ethics
- Increase Visibility Of Your Article
- Self Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Severe Preeclampsia
Current Women`s Health Reviews Glycobiology of Neural Stem Cells
CNS & Neurological Disorders - Drug Targets An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds Regulation and Quantification of Cellular Mitochondrial Morphology and Content
Current Pharmaceutical Design The Progress Towards the Development of DHQO Derivatives and Related Analogues with Inotropic Effects
Mini-Reviews in Medicinal Chemistry Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Current Drug Metabolism Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected
Current Pharmaceutical Design HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Current Neuropharmacology Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
Current Drug Targets - CNS & Neurological Disorders The Role of the Urokinase Receptor in Epilepsy, in Disorders of Language, Cognition, Communication and Behavior, and in the Central Nervous System
Current Pharmaceutical Design Editorial [Hot topic: Adenosine Receptor Ligands: Where Are We, and Where Are We Going? (Guest Editors: Tiziano Tuccinardi and Adriano Martinelli)]
Current Topics in Medicinal Chemistry An Update on GABAρ Receptors
Current Neuropharmacology Editorial [Hot Topic: The Pineal Hormone Melatonin in Health and Disease (Guest Editors: Charanjit Kaur)]
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
Current Neuropharmacology Role of Mesenchymal Stem Cells in Dermal Repair in Burns and Diabetic Wounds
Current Stem Cell Research & Therapy PET Radiotracers for Molecular Imaging of Serotonin 5-HT<sub>1A</sub> Receptors
Current Medicinal Chemistry Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant
Current Neuropharmacology Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics




